Recognizing Hepatitis R & D on World Hepatitis Day
Hepatitis is an inflammation of the liver, most commonly caused by a viral infection. There are five main hepatitis viruses, with types A, B, C most common. In 2018, the Centers for Disease Control and Prevention estimated that Americans were infected with 24,900 cases of hepatitis A and 21,600 cases of hepatitis B, many of which go undiagnosed because individuals do not know they are infected. Over the past several years, the biopharmaceutical industry has made significant progress in bringing medicines to patients that improve cure rates, reduce side effects and duration of treatment and expand treatment options. (Source: The Catalyst)
Source: The Catalyst - July 28, 2021 Category: Pharmaceuticals Tags: Research and Development Drug Cost Hepatitis C Source Type: news

Screening at a Federally Qualified Health Center in the Midwest for Hepatitis C Among People Who Inject Drugs, 2019-2020
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - July 15, 2021 Category: International Medicine & Public Health Tags: Public Health Source Type: news

The Cedar Project: exploring the role of colonial harms and childhood maltreatment on HIV and hepatitis C infection in a cohort study involving young Indigenous people who use drugs in two Canadian cities - Pearce ME, Jongbloed K, Pooyak S, Christian WM, Teegee MGWWM, Caron NR, Thomas V, Henderson E, Zamar D, Yoshida EM, Schechter MT, Spittal PM.
This study examined associations between childhood maltreatment, colonial harms and sex/drug-related risks for HIV and hepatitis C virus (HCV) infection among young Indigenous people who use drugs. DESIGN: The Cedar Project is a cohort ... (Source: SafetyLit)
Source: SafetyLit - July 12, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Hepatitis C vaccine could be rolled out within five years, says Nobel Prize winner who discovered virus
(European Society of Clinical Microbiology and Infectious Diseases) A vaccine to protect against infection with hepatitis C could be in use within 5 years, says Professor Sir Michael Houghton, who won the Nobel Prize for Medicine and Physiology along with three other scientists for discovering the hepatitis C virus (HCV) in 1989. Sir Michael will discuss the development of a vaccine in a special presentation at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 11, 2021 Category: International Medicine & Public Health Source Type: news

Appeals court upholds rationing of hepatitis C treatment
The Kentucky Department of Corrections can deny a life-saving but expensive hepatitis C medication to inmates (Source: ABC News: Health)
Source: ABC News: Health - July 10, 2021 Category: Consumer Health News Tags: Health Source Type: news

Rapid Hepatitis C Test Could Improve Diagnosis, Treatment
A simpler version of a test for the hepatitis C virus (HCV) may open testing to people in areas where medical care is limited. (Source: WebMD Health)
Source: WebMD Health - July 8, 2021 Category: Consumer Health News Source Type: news

Hepatitis C Antivirals May Fight SARS-CoV-2 Hepatitis C Antivirals May Fight SARS-CoV-2
Sofosbuvir/ledipasvir and nitazoxanide both appeared to clear SARS-CoV-2 infections in a preliminary trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2021 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

New Program to Develop Antivirals for COVID-19 New Program to Develop Antivirals for COVID-19
The Antiviral Program for Pandemics will allow the NIH to focus on antivirals for COVID-19 and other pandemic risks, including hemorrhagic fever and influenza, the way HIV and hepatitis C can be managed.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - June 17, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Hepatitis C Related Cognitive Impairment Hepatitis C Related Cognitive Impairment
This study assessed the prevalence and predictors of HCV-related cognitive impairment. Can it be reversed by anti-viral therapy?Journal of Viral Hepatitis (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - June 15, 2021 Category: Transplant Surgery Tags: Gastroenterology Journal Article Source Type: news

Malaysia registers first hepatitis C treatment developed through South-South cooperation
(Drugs for Neglected Diseases Initiative) New treatment combination for hepatitis C virus (HCV) is an additional affordable option for millions still waiting for access to lifesaving treatments in middle-income countries. Combination is safe and effective, including for hard-to-treat cases and people with HCV and HIV. New drug ravidasvir is the first HCV drug to be developed through South-South collaboration and with support from non-profit organizations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2021 Category: International Medicine & Public Health Source Type: news

U.S. Food and Drug Administration Approves New Formulation of Epclusa, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jun. 10, 2021-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved an expansion of the pediatric indication of Epclusa (sofosbuvir/velpatasvir) for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 10, 2021 Category: Drugs & Pharmacology Source Type: news

Liver Transplant Outcomes Improving for US Patients With HIV/HCV Liver Transplant Outcomes Improving for US Patients With HIV/HCV
Hepatitis C virus (HCV) infection no longer confers worse patient survival in the era of direct-acting antiviral therapy, but the population remains underserved.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - May 28, 2021 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

Africa: President Sisi Keen On Helping Africa Eradicate Hepatitis
[Egypt Online] President Abdel Fattah El Sisi is keen on supporting Africa in eliminating hepatitis through an initiative to treat one million Africans for hepatitis C, Health Minister Hala Zayed said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 28, 2021 Category: African Health Source Type: news

MAFLD As a Part of the Global Hepatitis C Elimination Effort MAFLD As a Part of the Global Hepatitis C Elimination Effort
Increasing evidence suggests that metabolic-associated fatty liver disease and chronic hepatitis C frequently coexist, especially in in HCV patients with SVR. What are the implications?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 24, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Wife of patient reacts to blood inquiry statement
Su’s husband Steve was diagnosed with hepatitis C 21 years after first receiving contaminated blood products. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 21, 2021 Category: Consumer Health News Source Type: news

When Medicare chips in on hepatitis C treatment for Medicaid patients, everyone wins
(University of Southern California) USC Schaeffer Center researchers found Medicare has significant financial incentives to partner with Medicaid to treat the majority of hepatitis C cases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 20, 2021 Category: Infectious Diseases Source Type: news

Opt-Out Increases Hepatitis C Screening Uptake
WEDNESDAY, May 19, 2021 -- Twice as many eligible patients get screened for hepatitis C virus (HCV) if it is already ordered for them at the time of a reminder, according to a study published online May 18 in The BMJ. Shivan J. Mehta, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 19, 2021 Category: Pharmaceuticals Source Type: news

Drops in Hepatitis C Testing, Treatment Spark Concern Drops in Hepatitis C Testing, Treatment Spark Concern
Prior to the pandemic, the goal was to eradicate this curable disease. Recent data suggest significant efforts will now be needed to make up for lost ground.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 19, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Drops in Hepatitis C Testing, Treatment
Spark Concern (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 19, 2021 Category: General Medicine Source Type: news

Why Do Patients With Chronic Hepatitis C Drink Alcohol? Why Do Patients With Chronic Hepatitis C Drink Alcohol?
This study examines how sociodemographic factors, chronic pain, and depression relate to the motivations of individuals with chronic HCV to consume alcohol.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 18, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Hepatitis C screening doubles when tests ordered ahead of time
(University of Pennsylvania School of Medicine) By sending eligible patients a screening order along with the usual reminder, researchers showed they could double hepatitis C screening rates (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 18, 2021 Category: Infectious Diseases Source Type: news

Hepatitis C Testing, Treatment Down During the Pandemic
MONDAY, May 17, 2021 -- The COVID-19 pandemic reduced routine hepatitis C virus (HCV) testing and treatment, according to a study published online May 10 in the American Journal of Preventive Medicine. Harvey W. Kaufman, M.D., from Quest... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2021 Category: Pharmaceuticals Source Type: news

Africa: New Drugs Work Against the Many Strains of Hepatitis C Found in African Countries
[The Conversation Africa] Around the world, 71 million people have been infected with the hepatitis C virus. The primary route of infection is through direct contact with another person's blood. This means the virus can be transmitted in a number of ways, including intravenous drug use, tattooing, contaminated blood or blood products and surgical procedures. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 2, 2021 Category: African Health Source Type: news

Ravidasvir-Sofosbuvir Combo Promising in Hep C Infection Ravidasvir-Sofosbuvir Combo Promising in Hep C Infection
A combination of ravidasvir and sofosbuvir appears to be an effective treatment for chronic hepatitis C virus infection across a diverse pool of patients who took part in a trial underway in Malaysia and Thailand.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 29, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Hepatitis C drugs multiply effect of COVID-19 antiviral Remdesivir
When combined with drugs currently used to treat hepatitis C, the antiviral remdesivir is 10 times more effective in treating cells infected with SARS-CoV-2, the virus that causes COVID-19. Published this week in Cell Reports, this finding - from Gaetano Montelione, a professor of chemistry and chemical biology at Rensselaer Polytechnic Institute, and his collaborators at the Icahn School of Medicine at Mount Sinai and the University of Texas at Austin - raises the potential for repurposing available drugs as COVID-19 antivirals in cases where a vaccine isn't practical or effective. (Source: World Pharma News)
Source: World Pharma News - April 27, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Hepatitis C drugs multiply effect of COVID-19 antiviral Remdesivir
(Rensselaer Polytechnic Institute) When combined with drugs currently used to treat hepatitis C, the antiviral remdesivir is 10 times more effective in treating cells infected with SARS-CoV-2, the virus that causes COVID-19. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 27, 2021 Category: International Medicine & Public Health Source Type: news

Hepatitis C drugs boost Remdesivir's antiviral activity against COVID-19
(University of Texas at Austin) Drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the SARS-CoV-2 coronavirus in cell cultures, according to a new study in Cell Reports. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 27, 2021 Category: International Medicine & Public Health Source Type: news

Hepatitis C drugs combined with Remdesivir show strong effectiveness against covid-19
(The Mount Sinai Hospital / Mount Sinai School of Medicine) A combination of remdesivir, a drug currently approved in the United States for treating COVID-19 patients, and repurposed drugs for hepatitis C virus (HCV) was 10 times more effective at inhibiting SARS-CoV-2, the virus that causes COVID-19. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 27, 2021 Category: Biology Source Type: news

HCV Antivirals Associated With Reduced Risk of CVD Events HCV Antivirals Associated With Reduced Risk of CVD Events
Hepatitis C virus infection has been associated with a greater risk of cardiovascular disease. Might antiviral therapy reduce the risk?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 9, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
Review (55 studies) found recent homelessness or unstable housing linked to increased risk of acquiring HIV (crude relative risk 1.55; 95% CI 1.23 –1.95; p=0.0002) and hepatitis C (1.65; 1.44–1.90; p (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 9, 2021 Category: Consumer Health News Source Type: news

Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India
India's Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 5, 2021 Category: Pharmaceuticals Source Type: news

ART Likely Less Effective in Women With HIV Versus Other Chronic Viral Illnesses ART Likely Less Effective in Women With HIV Versus Other Chronic Viral Illnesses
HIV-infected women who underwent assisted reproductive technology (ART) had a lower live birth rate than those with chronic hepatitis B or hepatitis C virus in a cohort study.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 1, 2021 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

Chronic viral infections can have lasting effects on human immunity, similar to aging
(Buck Institute for Research on Aging) Research suggests that chronic viral infections have a profound and lasting impact on the immune system in ways that are similar to those seen during aging. Using systems immunology and artificial intelligence, researchers profiled and compared immune responses in a cohort of aging individuals, people with HIV on anti-retroviral therapy, and people infected with hepatitis C before and after the virus was treated with a drug that has up to a 97% cure rate. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 29, 2021 Category: Infectious Diseases Source Type: news

Homelessness and unstable housing are associated with increased HIV and HCV risk among people who inject drugs
Homelessness and unstable housing are associated with a substantial increase in HIV and hepatitis C virus (HCV) acquisition risk among people who inject drugs, according to research led by the NIHR Health Protection Research Unit in Behavioural Science and Evaluation at the University of Bristol. (Source: University of Bristol news)
Source: University of Bristol news - March 26, 2021 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences; Press Release Source Type: news

Babies are being born with congenital syphilis in Sask. This is a public health emergency
We are about to see a third pandemic. Few are thinking about it, but it's keeping me up at night. This is a monster with three heads: HIV, syphilis and hepatitis C.   (Source: CBC | Health)
Source: CBC | Health - March 26, 2021 Category: Consumer Health News Tags: News/Canada/Saskatchewan Source Type: news

In trying to contain COVID-19, we could be missing spread of HIV, hepatitis C and syphilis, experts warn
Public health experts say the COVID-19 pandemic has overshadowed other epidemics that need attention. Testing for HIV and hepatitis C has plummeted in Saskatchewan, where blood-borne and sexually transmitted infections continue to spread at alarming rates. (Source: CBC | Health)
Source: CBC | Health - March 26, 2021 Category: Consumer Health News Tags: News/Canada/Saskatchewan Source Type: news

Ukrainian Traffickers Sentenced for Counterfeit Cancer and Hepatitis Drugs
FDA OCI, Maksym Nienadov, Healthy Nation, Volodymyr Nikolaienko, Ukraine, counterfeit drug, smuggling, misbranded medicine, Keytruda, Abraxane, Epclusa, cancer, hepatitis C, oncology drug, undercover purchase, custody, prescription drugs, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - March 25, 2021 Category: Medical Law Authors: DOJ Source Type: news

Pfizer is now testing a COVID-19 pill
The treatment is a potent protease inhibitor, the same kind of technology used to treat HIV and hepatitis C. (Source: Reuters: Health)
Source: Reuters: Health - March 24, 2021 Category: Consumer Health News Source Type: news

End Vaccine Apartheid Before Millions More Die
By Anis Chowdhury and Jomo Kwame SundaramSYDNEY and KUALA LUMPUR, Mar 23 2021 (IPS) At least 85 poor countries will not have significant access to coronavirus vaccines before 2023. Unfortunately, a year’s delay will cause an estimated 2.5 million avoidable deaths in low and lower-middle income countries. As the World Health Organization (WHO) Director-General has put it, the world is at the brink of a catastrophic moral failure. Anis Chowdhury Vaccine apartheid The EU, US, UK, Switzerland, Canada and their allies continue to block the developing country proposal to temporarily suspend the World Trade Organization (W...
Source: IPS Inter Press Service - Health - March 23, 2021 Category: International Medicine & Public Health Authors: Anis Chowdhury and Jomo Kwame Sundaram Tags: Development & Aid Economy & Trade Featured Global Headlines Health Human Rights Humanitarian Emergencies TerraViva United Nations Source Type: news

Neutrons reveal unpredicted binding between SARS-CoV-2, hepatitis C antiviral drug
(DOE/Oak Ridge National Laboratory) Researchers at the Oak Ridge National Laboratory used neutron scattering to investigate the interactions between telaprevir, a drug used to treat hepatitis C viral infection, and the SARS-CoV-2 main protease, the enzyme responsible for enabling the virus to reproduce. Unforeseen changes in the electric charges were discovered in the drug binding site of the protease enzyme that were not predicted by prevailing computer simulations. The research provides key insights for advancing drug design and drug repurposing efforts to treat COVID-19. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 23, 2021 Category: International Medicine & Public Health Source Type: news

Roche awarded WHO prequalification for the HIV and HCV tests on the cobas 6800/8800 Systems
Basel, 11 March 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the cobas ® HIV-1 and cobas® HCV Tests for use on the cobas® 6800/8800 Systems have been awarded World Health Organization (WHO) prequalification. WHO prequalification helps regulators and procurers in low and middle-income countries to identify products that meet high quality standards and are safe and su itable for their intended use. This is of benefit to healthcare professionals and patients, for whom quality assured IVDs are essential for effective diagnosis and monitoring of therapeutic efficiency.  Increased access to dia...
Source: Roche Media News - March 11, 2021 Category: Pharmaceuticals Source Type: news

Roche awarded WHO prequalification for the HIV and HCV tests on the cobas 6800/8800 Systems
Basel, 11 March 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the cobas ® HIV-1 and cobas® HCV Tests for use on the cobas® 6800/8800 Systems have been awarded World Health Organization (WHO) prequalification. WHO prequalification helps regulators and procurers in low and middle-income countries to identify products that meet high quality standards and are safe and su itable for their intended use. This is of benefit to healthcare professionals and patients, for whom quality assured IVDs are essential for effective diagnosis and monitoring of therapeutic efficiency.  Increased access to dia...
Source: Roche Investor Update - March 11, 2021 Category: Pharmaceuticals Source Type: news

ICYMI: WSJ showcases breakthrough science of COVID-19 vaccines and implications for future medicines
Building on deep scientific knowledge gained from decades of experience with viruses such as MERS, SARS, influenza, HIV and Hepatitis C, biopharmaceutical companies have madeunprecedented progress in advancing treatments and vaccines to help fight COVID-19. At this time, three vaccines and several treatments have received emergency use authorizations (EUAs) from the U.S. Food and Drug Administration (FDA) with one treatment receiving FDA approval. Additional candidates under investigation have also shown promise. (Source: The Catalyst)
Source: The Catalyst - March 8, 2021 Category: Pharmaceuticals Tags: Vaccines Coronavirus Source Type: news

La FDA advierte del riesgo de sufrir da ños hepáticos graves con los tratamientos de Viekira Pak y Technivie contra la hepatitis C
[10/22/2015] La Administraci ón de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) está advirtiendo que los tratamientos de Viekira Pak y Technivie contra la hepatitis C pueden causar daños hepáticos graves, sobre todo en pacientes con una enfermedad del hígado subyacente en etapa avanzada. En consecuencia, estamos exigiéndole al fabricante que añada nueva información sobre este riesgo de seguridad a las etiquetas de información farmacológica. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 26, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Liver Cancer Profile Differs in Black Patients With Hep C
THURSDAY, Feb. 25, 2021 -- Black patients with hepatitis C virus (HCV) infection develop hepatocellular carcinoma (HCC) at an earlier disease stage and have better liver function at the time of diagnosis, according to a study published online Feb.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 25, 2021 Category: Pharmaceuticals Source Type: news

Why Is Liver Cancer More Lethal for Black Patients?
THURSDAY, Feb 26, 2021 -- Black people with hepatitis C develop liver cancer sooner than people in other racial groups and the cancer is often more aggressive, but current screening guidelines may not be broad enough to catch these cases early,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 25, 2021 Category: General Medicine Source Type: news

Hepatitis C and HIV Combined Screening in Primary Care Hepatitis C and HIV Combined Screening in Primary Care
This study evaluated the effectiveness of a combined screening program for HCV and HIV, which included a risk-assessment questionnaire and rapid tests for point-of-care diagnosis.Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 25, 2021 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news

Comunicado de la FDA sobre la seguridad de los medicamentos: Severas reacciones cut áneas después de tratamiento combinado con los medicamentos Incivek (telaprevir), peginterferón alfa y ribavirina para la hepatitis C
El 19 de diciembre del 2012, La Administraci ón de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) recibió informes sobre severas reacciones de la piel, algunas de ellas fatales, en pacientes que toman el medicamento Incivek (telaprevir) para la hepatitis C en combinación con los fármacos peginterferón alfa y ri bavirina (tratamiento combinado con Incivek). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 19, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Characteristics of SARS-CoV-2 Infection in Persons With HCV Characteristics of SARS-CoV-2 Infection in Persons With HCV
How prevalent is SARS-CoV-2 infection among persons with hepatitis C? Does stage of liver fibrosis impact infection rates?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 11, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Association of Hepatitis C Infection and Risk of Kidney Cancer Association of Hepatitis C Infection and Risk of Kidney Cancer
Do patients with hepatitis C have a significantly higher risk of developing kidney cancer?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 11, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news